Current joint therapy usage in equine practice: a survey of veterinarians 2009.
Abstract: Medications are frequently employed to treat intra-articular (IA) problems in the performance horse. Actual usage of the different IA medications in horses is not available. Objective: To determine the most common usage of these medications, members of the American Association of Equine Practitioners (AAEP) were surveyed. Methods: An email link to an online survey was electronically sent to 6305 AAEP members and the responses tabulated and analysed with a logistic regression model. Results: A total of 831 survey responses were submitted and tabulated. Eighty per cent of the respondents indicated that they see 100% equine cases in their practice. The majority of respondents (77%) use triamcinolone acetonide (TA) to treat high motion joints and 73% use methylprednisolone acetate (MPA) to treat low motion joints. Veterinarians treating the Western performance and Sport horse were significantly more likely to use TA in high motion joints compared to MPA (P = 0.0201 and P<0.0001, respectively). Triamcinolone acetonide use compared to MPA in high motion joints by racehorse veterinarians was significantly lower compared to other veterinarians (P<0.0001). Polysulphated glycosaminoglycan (Adequan) and hyaluronate sodium (Legend) were the most commonly used disease modifying products (63 and 57% of respondents, respectively). Sport horse practitioners were significantly more likely than race or show horse veterinarians to utilise IRAP products (P = 0.0035 and P = 0.04, respectively). Respondents who had been in practice for more than 10 years were significantly less likely to use antimicrobials in their joint injections compared to those in practice for less than 10 years (P<0.0001). Conclusions: Significant differences existed in usage of medications related to primary discipline treated and years practicing. Conclusions: The results of this study aid in defining the current usage of different joint therapy medications within equine practice. This knowledge can guide further research as well as education.
© 2011 EVJ Ltd.
Publication Date: 2011-06-13 PubMed ID: 21668486DOI: 10.1111/j.2042-3306.2010.00324.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
- Research Support
- Non-U.S. Gov't
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
This research article is a survey of American equine veterinarians, exploring the most commonly used joint therapies and findings dependent on factors such as practitioner experience and the patient’s primary discipline.
Objective of the Study
- The main aim of this paper was to provide detailed information on the current use of different intra-articular (IA) medications in horses, as known from practicing equine veterinarians.
- The researchers wanted to determine the most commonly used medications for treating IA problems in performance horses and if their use varies based on factors like the horse’s discipline or the years of experience the veterinarian has.
Methodology
- An online survey was designed and the link was electronically mailed to 6305 members of the American Association of Equine Practitioners (AAEP). The data collected via these surveys was then analyzed using a logistic regression model.
Results and Analysis
- The study received 831 responses which were subsequently analyzed.
- Most of the respondents (80%) have a fully equine practice.
- Findings revealed that the majority of respondents (77%) used triamcinolone acetonide (TA) to treat high motion joints while 73% used methylprednisolone acetate (MPA) to treat low motion joints.
- The use of TA for high motion joints was significantly found more among veterinarians dealing with Western performance and Sport horses than those who used MPA.
- Racehorse veterinarians, however, were significantly less likely to use TA in high motion joints as compared to other veterinarians.
- Polysulphated glycosaminoglycan (Adequan) and hyaluronate sodium (Legend) were found to be the most commonly used products for disease modification (63% and 57% of respondents, respectively).
- Sport horse practitioners significantly preferred to use IRAP products compared to race or show horse veterinarians.
- Veterinarians who had been practicing for over 10 years were less likely to use antimicrobials in their joint injections than those in practice for less than 10 years. This difference was statistically significant.
Conclusions
- The paper concludes by highlighting significant differences in the use of medications relating to the primary discipline of treatment and the years of practice.
- The results of this survey are considered beneficial for defining current joint therapy medication usage in equine practice. This knowledge can guide future research and contribute to the education of practitioners.
Cite This Article
APA
Ferris DJ, Frisbie DD, McIlwraith CW, Kawcak CE.
(2011).
Current joint therapy usage in equine practice: a survey of veterinarians 2009.
Equine Vet J, 43(5), 530-535.
https://doi.org/10.1111/j.2042-3306.2010.00324.x Publication
Researcher Affiliations
- Gail Holmes Equine Orthopaedic Research Center, Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, CO, USA.
MeSH Terms
- Animals
- Anti-Bacterial Agents / administration & dosage
- Anti-Bacterial Agents / therapeutic use
- Anti-Inflammatory Agents / administration & dosage
- Anti-Inflammatory Agents / therapeutic use
- Data Collection
- Glycosaminoglycans / administration & dosage
- Glycosaminoglycans / therapeutic use
- Horse Diseases / drug therapy
- Horses
- Injections, Intra-Articular
- Interleukin-1 Receptor Accessory Protein / administration & dosage
- Interleukin-1 Receptor Accessory Protein / therapeutic use
- Joint Diseases / drug therapy
- Joint Diseases / veterinary
- Surveys and Questionnaires
Citations
This article has been cited 19 times.- Zhu Y, Fu W. Peripheral Blood-Derived Stem Cells for the Treatment of Cartilage Injuries: A Systematic Review. Front Bioeng Biotechnol 2022;10:956614.
- Knott LE, Fonseca-Martinez BA, O'Connor AM, Goodrich LR, McIlwraith CW, Colbath AC. Current use of biologic therapies for musculoskeletal disease: A survey of board-certified equine specialists. Vet Surg 2022 May;51(4):557-567.
- Krause DM, Pezzanite LM, Griffenhagen GM, Hendrickson DA. Comparison of equine synovial sepsis rate following intrasynovial injection in ambulatory versus hospital settings. Equine Vet J 2022 May;54(3):523-530.
- Camargo Garbin L, Morris MJ. A Comparative Review of Autologous Conditioned Serum and Autologous Protein Solution for Treatment of Osteoarthritis in Horses. Front Vet Sci 2021;8:602978.
- Velloso Alvarez A, Boone LH, Braim AP, Taintor JS, Caldwell F, Wright JC, Wooldridge AA. A Survey of Clinical Usage of Non-steroidal Intra-Articular Therapeutics by Equine Practitioners. Front Vet Sci 2020;7:579967.
- MacKay AV, McOnie RC, Riddell LP, Robinson KA. Characterization of the use of shock wave therapy among equine veterinarians. Can Vet J 2020 Sep;61(9):990-993.
- Velloso Alvarez A, Boone LH, Pondugula SR, Caldwell F, Wooldridge AA. Effects of Autologous Conditioned Serum, Autologous Protein Solution, and Triamcinolone on Inflammatory and Catabolic Gene Expression in Equine Cartilage and Synovial Explants Treated With IL-1β in Co-culture. Front Vet Sci 2020;7:323.
- Pezzanite L, Chow L, Piquini G, Griffenhagen G, Ramirez D, Dow S, Goodrich L. Use of in vitro assays to identify antibiotics that are cytotoxic to normal equine chondrocytes and synovial cells. Equine Vet J 2021 May;53(3):579-589.
- Marques-Smith P, Kallerud AS, Johansen GM, Boysen P, Jacobsen AM, Reitan KM, Henriksen MM, Löfgren M, Fjordbakk CT. Is clinical effect of autologous conditioned serum in spontaneously occurring equine articular lameness related to ACS cytokine profile?. BMC Vet Res 2020 Jun 8;16(1):181.
- Neuenschwander HM, Moreira JJ, Vendruscolo CP, Fülber J, Seidel SRT, Michelacci YM, Baccarin RYA. Hyaluronic acid has chondroprotective and joint-preserving effects on LPS-induced synovitis in horses. J Vet Sci 2019 Nov;20(6):e67.
- Broeckx SY, Martens AM, Bertone AL, Van Brantegem L, Duchateau L, Van Hecke L, Dumoulin M, Oosterlinck M, Chiers K, Hussein H, Pille F, Spaas JH. The use of equine chondrogenic-induced mesenchymal stem cells as a treatment for osteoarthritis: A randomised, double-blinded, placebo-controlled proof-of-concept study. Equine Vet J 2019 Nov;51(6):787-794.
- Wilson JM, McKenzie E, Duesterdieck-Zellmer K. International Survey Regarding the Use of Rehabilitation Modalities in Horses. Front Vet Sci 2018;5:120.
- Bogers SH. Cell-Based Therapies for Joint Disease in Veterinary Medicine: What We Have Learned and What We Need to Know. Front Vet Sci 2018;5:70.
- White GW. Polysulfated glycosaminoglycan as a treatment for osteoarthritis in veterinary medicine: Summary of the pharmacological, laboratory, and clinical data. Open Vet J 2025 Sep;15(9):4007-4023.
- Hardefeldt L, Thomas K, Page S, Norris J, Browning G, El Hage C, Stewart A, Gilkerson J, Muscatello G, Verwilghen D, van Galen G, Bauquier J, Cuming R, Reynolds B, Whittaker C, Wilkes E, Clulow J, Burden C, Begg L. Antimicrobial prescribing guidelines for horses in Australia. Aust Vet J 2025 Dec;103(12):781-889.
- Guidoni K, Chiaradia E, Pepe M, Di Meo A, Tognoloni A, Seccaroni M, Beccati F. The Combined Use of Triamcinolone and Platelet-Rich Plasma in Equine Metacarpophalangeal Joint Osteoarthritis Treatments: An In Vivo and In Vitro Study. Animals (Basel) 2024 Dec 17;14(24).
- Aragona F, Tabbì M, Gugliandolo E, Giannetto C, D'Angelo F, Fazio F, Interlandi C. Role of cannabidiolic acid or the combination of cannabigerol/cannabidiol in pain modulation and welfare improvement in horses with chronic osteoarthritis. Front Vet Sci 2024;11:1496473.
- Sundar S, Koopman A, Manzoni TJ, Xie W, Bhatti QU, Lo CY, Damani VS, Yang AN, Pochan D, Parreno J, Engiles JB, Kayser LV, Dhong C. Kinetics and Retention of Polystyrenesulfonate for Proteoglycan Replacement in Cartilage. Biomacromolecules 2024 Sep 9;25(9):5819-5833.
- Gregg SR, Barshick MR, Johnson SE. Intravenous Injection of Sodium Hyaluronate Diminishes Basal Inflammatory Gene Expression in Equine Skeletal Muscle. Animals (Basel) 2023 Sep 27;13(19).
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists
